An enzyme found at elevated levels in several human cancers has been linked to abnormal tumor growth in fruit flies, a discovery that provides a new model for understanding the link between stem cell biology and cancer, according to researchers at the University of Oregon.
Almost four in five Australians (78 percent) support mandatory fitness testing for school children to combat childhood obesity, according to a new public opinion poll by Research Australia.
Tissue regeneration strategies, such as stem cell research, have undergone notable developments over the past two decades. However, an article in the journal, Artificial Organs, suggests that many challenges must be overcome before regenerative medicine is accepted as a viable science.
Science may be one step closer to understanding how a limb can be grown or a spinal cord can be repaired. Scientists at The Forsyth Institute have discovered that some cells have to die for regeneration to occur.
A team from the Medical College of Wisconsin in Milwaukee has applied for a patent on their work to isolate, grow and identify a new and readily-available type of adult stem cell that is found in the bulge of hair follicles, and appears to have a potential for diversification similar to that of embryonic stem cells.
Interim data from a clinical trial using Aldagen’s product, ALDESORT? to isolate stem cells from cord blood was presented at the 48th Annual Meeting of the American Society of Hematology demonstrating improved safety and efficacy when using ALDESORT compared to the COBLT control group. The trial is being conducted by Joanne Kurtzberg, MD, the Duke University physician who pioneered the use of umbilical cord blood as treatment for fatal childhood cancers and genetic diseases.
Most patients undergoing bone-marrow transplant must receive powerful chemotherapy drugs to suppress their immune system and prevent their bodies from rejecting the donated cells. New research shows that this chemotherapy increases the risk for graft-versus-host disease — but also suggests that this risk can be reduced by replacing a natural antibiotic that’s depleted when patients undergo chemotherapy. A multicenter study led by Children’s Hospital Boston and the Dana-Farber Cancer Institute is about to test this idea.
Mayo Clinic Cancer Center, in collaboration with researchers from the University of Iowa, today presented results of a Phase II clinical study indicating that an oral drug, tipifarnib, can stall or reverse disease progression for patients with relapsed aggressive non-Hodgkin lymphoma.
At the 2006 American Society for Cell Biology conference, scientists present the first research findings of a system that can pattern the formation of multiiple tissues from a single population of adult stem cells.
New Jersey government agreed on a $500 million plan to finance stem-cell studies, almost three years after the state became the second in the U.S. to legalize the research.